Evaluation of the commercial kit SIRE Nitratase for detecting resistant Mycobacterium tuberculosis in Brazil

xmlui.dri2xhtml.METS-1.0.item-date
2017xmlui.dri2xhtml.METS-1.0.item-files-viewOpen
xmlui.mirage2.itemSummaryView.MetaData
xmlui.ArtifactBrowser.ItemViewer.show_fullxmlui.dri2xhtml.METS-1.0.item-uri
http://patua.iec.gov.br//handle/iec/2870xmlui.dri2xhtml.METS-1.0.item-author
Miranda, Silvana Spindola de
Almeida, Isabela Neves de
Lopes, Maria Luiza
Figueiredo, Jamilly dos Reis de
Figueredo, Lida Jouca de Assis
Kritski, Afrânio Lineu
Carvalho, Wânia da Silva
Mansur, Maria de Fátima Filardi Oliveira
xmlui.dri2xhtml.METS-1.0.item-abstract
Introduction: This study aimed to evaluate a new commercial kit, Kit SIRE Nitratase-PlastLabor, for testing the drug susceptibility
of clinical Mycobacterium tuberculosis isolates. Methods: The accuracy of the Kit SIRE Nitratase was evaluated by examining
the susceptibility (streptomycin, isoniazid, rifampicin, and ethambutol) of 40 M. tuberculosis isolates, using the proportion method
with Lowenstein-Jensen medium or the BACTEC MGIT 960 system. Results: The detection accuracy for streptomycin, isoniazid,
rifampicin, and ethambutol was 95%, 97.5%, 100%, and 80%, respectively. Conclusions: The exceptional accuracy demonstrated
by Kit SIRE Nitratase for isoniazid and rifampicin makes the kit an attractive option for screening M. tuberculosis strain resistance.
xmlui.dri2xhtml.METS-1.0.item-citation
MIRANDA, Silvana Spindola de et al. Evaluation of the commercial kit SIRE Nitratase for detecting resistant Mycobacterium tuberculosis in Brazil. Revista da Sociedade Brasileira de Medicina Tropical, v. 50, n. 4, p. 550-553, July-Aug. 2017.xmlui.dri2xhtml.METS-1.0.item-decsPrimary
Mycobacterium tuberculosisMycobacterium tuberculosis / efeitos de drogas
Genes MDR / efeitos de drogas
Nitrato Redutase
Kit SIRE